Advertisement
Screener

HYPERION DEFI, INC. (HYPD) Diluted Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

HYPERION DEFI, INC. Diluted Shares Outstanding (Weighted Average)

HYPERION DEFI, INC. (HYPD) reported Diluted Shares Outstanding (Weighted Average) of 17.04 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-13

  • HYPERION DEFI, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 17.04M shares, a 384.25% increase year-over-year.
  • HYPERION DEFI, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 12.69M shares, a 479.56% increase year-over-year.
  • HYPERION DEFI, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 8.21M shares, a 576.14% increase year-over-year.
  • HYPERION DEFI, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 28.95M shares, a 3229.80% increase year-over-year.
  • HYPERION DEFI, INC. weighted average number of shares outstanding, diluted for fiscal 2025 was 5.00M shares, a 500.28% increase from fiscal 2024.
  • HYPERION DEFI, INC. weighted average number of shares outstanding, diluted for fiscal 2024 was 833.00K shares, a 62.41% increase from fiscal 2023.
  • HYPERION DEFI, INC. weighted average number of shares outstanding, diluted for fiscal 2023 was 512.91K shares, a 98.48% decline from fiscal 2022.
  • HYPERION DEFI, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 33.65M shares, a 27.83% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Diluted 3 monthWeighted Average Number of Shares Outstanding, Diluted 3 month as first filedWeighted Average Number of Shares Outstanding, Diluted 6 monthWeighted Average Number of Shares Outstanding, Diluted 6 month as first filedWeighted Average Number of Shares Outstanding, Diluted 9 monthWeighted Average Number of Shares Outstanding, Diluted 9 month as first filedWeighted Average Number of Shares Outstanding, Diluted 12 monthWeighted Average Number of Shares Outstanding, Diluted 12 month as first filed
2026-06-3017.04M shares
10-Q · filed 2026-08-13
14.87M shares
10-Q · filed 2026-08-13
12.65M shares
derived: average of 3 quarters · filed 2026-08-13
16.72M shares
derived: average of 4 quarters · filed 2026-08-13
2026-03-3112.69M shares
10-Q · filed 2026-05-15
10.45M shares
derived: average of 2 quarters · filed 2026-05-15
16.62M shares
derived: average of 3 quarters · filed 2026-05-15
13.34M shares
derived: average of 4 quarters · filed 2026-08-13
2025-12-318.21M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
18.58M shares
derived: average of 2 quarters · filed 2026-03-30
13.56M shares
derived: average of 3 quarters · filed 2026-08-13
5.00M shares
10-K · filed 2026-03-30
2025-09-3028.95M shares
10-Q · filed 2025-11-14
16.24M shares
derived: average of 2 quarters · filed 2026-08-13
3.93M shares
10-Q · filed 2025-11-14
8.97M shares
derived: average of 4 quarters · filed 2026-08-13
2025-06-303.52M shares
10-Q · filed 2026-08-13
2.86M shares
10-Q · filed 2026-08-13
2.31M shares
derived: average of 3 quarters · filed 2026-08-13
1.95M shares
derived: average of 4 quarters · filed 2026-08-13
2025-03-312.19M shares
10-Q · filed 2026-05-15
1.70M shares
derived: average of 2 quarters · filed 2026-05-15
1.42M shares
derived: average of 3 quarters · filed 2026-05-15
1.23M shares
derived: average of 4 quarters · filed 2026-05-15
2024-12-311.21M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
1.04M shares
derived: average of 2 quarters · filed 2026-03-30
915.87K shares
derived: average of 3 quarters · filed 2026-03-30
833.00K shares
10-K · filed 2026-03-30
2024-09-30869.48K shares
10-Q · filed 2025-11-14
69.56M shares
10-Q · filed 2024-11-12
766.75K shares
derived: average of 2 quarters · filed 2025-11-14
705.96K shares
10-Q · filed 2025-11-14
56.48M shares
10-Q · filed 2024-11-12
-27.88M shares
derived: average of 4 quarters · filed 2025-11-14
2024-06-30664.02K shares
10-Q · filed 2025-08-13
53.12M shares
10-Q · filed 2024-08-14
623.30K shares
10-Q · filed 2025-08-13
49.86M shares
10-Q · filed 2024-08-14
-37.46M shares
derived: average of 3 quarters · filed 2025-08-13
-18.06M shares
derived: average of 4 quarters · filed 2025-08-13
2024-03-31582.58K shares
10-Q · filed 2025-05-19
46.61M shares
10-Q · filed 2024-05-15
-56.53M shares
derived: average of 2 quarters · filed 2025-05-19
-24.31M shares
derived: average of 3 quarters · filed 2025-05-19
-8.71M shares
derived: average of 4 quarters · filed 2025-05-19
2023-12-31-113.64M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15
-36.75M shares
derived: average of 2 quarters · filed 2025-04-15
-11.80M shares
derived: average of 3 quarters · filed 2025-04-15
512.91K shares
10-K · filed 2025-04-15
41.03M shares
10-K · filed 2024-03-18
2023-09-3040.14M shares
10-Q · filed 2024-11-12
39.12M shares
derived: average of 2 quarters · filed 2024-11-12
38.56M shares
10-Q · filed 2024-11-12
37.98M shares
derived: average of 4 quarters · filed 2024-11-12
2023-06-3038.09M shares
10-Q · filed 2024-08-14
37.75M shares
10-Q · filed 2024-08-14
37.26M shares
derived: average of 3 quarters · filed 2024-08-14
36.60M shares
derived: average of 4 quarters · filed 2024-08-14
2023-03-3137.41M shares
10-Q · filed 2024-05-15
36.84M shares
derived: average of 2 quarters · filed 2024-05-15
36.10M shares
derived: average of 3 quarters · filed 2024-05-15
35.49M shares
derived: average of 4 quarters · filed 2024-05-15
2022-12-3136.26M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18
35.45M shares
derived: average of 2 quarters · filed 2024-03-18
34.85M shares
derived: average of 3 quarters · filed 2024-03-18
33.65M shares
10-K · filed 2024-03-18
2022-09-3034.63M shares
10-Q · filed 2023-11-13
34.14M shares
derived: average of 2 quarters · filed 2023-11-13
32.78M shares
10-Q · filed 2023-11-13
31.57M shares
derived: average of 4 quarters · filed 2023-11-13
2022-06-3033.64M shares
10-Q · filed 2023-08-11
31.84M shares
10-Q · filed 2023-08-11
30.54M shares
derived: average of 3 quarters · filed 2023-08-11
29.42M shares
derived: average of 4 quarters · filed 2023-08-11
2022-03-3130.01M shares
10-Q · filed 2023-05-12
28.99M shares
derived: average of 2 quarters · filed 2023-05-12
28.01M shares
derived: average of 3 quarters · filed 2023-05-12
27.49M shares
derived: average of 4 quarters · filed 2023-05-12
2021-12-3127.98M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
27.02M shares
derived: average of 2 quarters · filed 2023-03-31
26.65M shares
derived: average of 3 quarters · filed 2023-03-31
26.32M shares
10-K · filed 2023-03-31
2021-09-3026.05M shares
10-Q · filed 2022-11-14
26.05M shares
10-Q · filed 2021-11-12
25.99M shares
derived: average of 2 quarters · filed 2022-11-14
25.77M shares
10-Q · filed 2022-11-14
25.53M shares
derived: average of 4 quarters · filed 2022-11-14
2021-06-3025.93M shares
10-Q · filed 2022-08-11
25.63M shares
10-Q · filed 2022-08-11
25.36M shares
derived: average of 3 quarters · filed 2022-08-11
24.57M shares
derived: average of 4 quarters · filed 2022-08-11
2021-03-3125.33M shares
10-Q · filed 2022-05-13
25.07M shares
derived: average of 2 quarters · filed 2022-05-13
24.12M shares
derived: average of 3 quarters · filed 2022-05-13
2020-12-3124.81M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30
23.51M shares
derived: average of 2 quarters · filed 2022-03-30
21.05M shares
10-K · filed 2022-03-30
2020-09-3022.21M shares
10-Q · filed 2021-11-12
19.80M shares
10-Q · filed 2021-11-12

Similar stocks

Stock NameCountryMarket CapPE Ratio
Rein Therapeutics, Inc. (RNTX)United States$0.063B-1.76
XBiotech Inc. (XBIT)United States$0.066B-1.56
Skye Bioscience, Inc. (SKYE)United States$0.061B-0.48
CalciMedica, Inc. (CALC)United States$0.061B-1.42
TALPHERA, INC. (TLPH)United States$0.060B
Connect Biopharma Holdings Ltd (CNTB)$0.069B-2.17
Yarrow Bioscience, Inc. (YARW)United States$0.070B
Boundless Bio, Inc. (BOLD)United States$0.059B-0.88
NOMAD POWER SOLUTIONS, INC. (NMAD)United States$0.058B
PLIANT THERAPEUTICS, INC. (PLRX)United States$0.071B-0.76